Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Myeloproliferative Disorders 5Myelodysplastic Syndromes 5Primary Myelofibrosis 4Anemia 4beta-Thalassemia 2Leukemia, Myeloid, Acute 2Thrombocytosis 1Higher-risk Myelodysplastic Syndrome 1Hematologic Neoplasms 1Granulosa cell tumor of the ovary 1

Interventions

nirogacestat 1luspatercept 1luprolide acetate gel depot 1exemestane 1etoposide phosphate 1darolutamide 1X-Rays 1Taxes 1Specimen Handling 1Platinum 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Leuprolide 1Immunoglobulin G 1Disulfides 1Cisplatin 1Carboplatin 1Bleomycin 1Bevacizumab 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Granulosa cell tumor of the ovary × luspatercept × Clear all
NCT06254781 2024-02-12

Luspatercept in Metastatic AGCT of the Ovary

University Health Network, Toronto

Phase NA Completed
1 enrolled

Granulosa cell tumor of the ovary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡